Joana Gameiro

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Acute kidney injury in patients with severe sepsis or septic shock: a comparison between the ‘Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease’ (RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease: Improving Global Outcomes (KDIGO) classifications

Marta Pereira, Natacha Rodrigues, Iolanda Godinho et al. · Clinical Kidney Journal · 2016 · 72 citations · Full text

Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis

Joana Gameiro, Joana B. Neves, Natacha Rodrigues et al. · Clinical Kidney Journal · 2016 · 68 citations · Full text

Neutrophil, lymphocyte and platelet ratio as a predictor of postoperative acute kidney injury in major abdominal surgery

Joana Gameiro, José Agapito Fonseca, Joana Monteiro Dias et al. · BMC Nephrology · 2018 · 61 citations · Full text